Author/Editor | Neumann, Hartmut PH; Eng, Charis; Mulligan, Lois M; Glavač, Damjan; Zaeuner, Ingeborg; Ponder, Bruce A J; Crossey, Paul A; Maher, Eamonn R; Brauch, Hiltrud | |
Title | Consequences of direct genetic testing for germline mutations in the clinical management of families with multiple endocrine neoplasia, type II | |
Type | članek | |
Source | JAMA | |
Vol. and No. | Letnik 274, št. 14 | |
Publication year | 1995 | |
Volume | str. 1149-51 | |
Language | eng | |
Abstract | Objective.-Multiple endocrine neoplasia, type II (MEN-II) is an autosomal dominant disorder characterized by tumors thyroid C cells and pheochromocytoma. Recently, germline mutations in the RET proto-oncogene have been identified in patients with MEN-II. The aims of the study were (1) to define the mutations in clinically diagnosed MEN-II families, (2) to compare the results of genetic and biochemical testing, and (3) to evaluate the impact of mutation analyses for the members of these families. Design.-Register-based survey study of clinically affected and unaffected members of MEN-II families. Setting.-Register of families from Germany and Spain with pheochromocytomas. Two research laboratories at Cambridge University in the United Kingdom. Patients.-We investigated consenting affected and unaffected members belonging to a series of 10 families who met the clinical criteria for MEN-II. Main Outcome Measures.-(1) Presence or absence of germline mutation in the RET proto-oncogene in affected and unaffected members of the 10 families, and (2) in the absence of RET mutation in a given family, presence or absence of germline mutation in the von Hippel-Lindau (VHL) gene, which is the susceptibility gene involved in a closely related syndrome, von Hippel-Lindau disease. Results.-In eight of these families, RET mutations were identified. The specific mutations were detected in all affected members. The remaining two families without RET mutations were subsequently shown to have a mutation within the VHL gene. The VHL mutations were identified in both families and represent a previosly undescribed base change. After identification of the mutation, premorbid genetic testing was performed in all MEN-II and VHL families, resulting in detection of asymptomatic carriers in the MEN-II families by the presence of a C-cell tumor in only one individual from each family and extra-adrenal pheochromocytoma in three of nine affected individuals in the two families combined.(trunc.) | |
Descriptors | MULTIPLE ENDOCRINE NEOPLASIA GERM-LINE MUTATION ADOLESCENCE ADULT MIDDLE AGE AGED CHILD, PRESCHOOL CHILD POLYMERASE CHAIN REACTION PROTO-ONCOGENES |